<DOC>
	<DOC>NCT01239589</DOC>
	<brief_summary>This study is being carried out to find out how patients suffering from the acute manic phase of bipolar disease are currently managed with Quetiapine Immediate Release (IR) or Quetiapine Extended Release (XR) in the hospital setting in real life practice, including length of stay.</brief_summary>
	<brief_title>European Study to Describe Hospital Stay in Patients Admitted for Acute Bipolar Manic Episodes</brief_title>
	<detailed_description />
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Patients diagnosed with Bipolar Disorder (ICD10). Admitted for acute bipolar manic episode from 1st October 2009 to 1st October 2010 Patients treated with quetiapine IR or quetiapine XR during the hospitalization period. Patients in which BD is not the main reason for hospitalization Patients admitted for acute bipolar mania episodes but finally diagnosed with mixed or bipolar disorder not otherwise specified (NOS) episodes Patients receiving both quetiapine IR and XR during the same hospitalization period.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Patients admitted as for an acute bipolar manic episode</keyword>
	<keyword>Description of management patterns and hospital stay in patients admitted for acute bipolar manic episode and treated with either quetiapine IR or quetiapine XR</keyword>
</DOC>